NCT02279823 - A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions

Androgenetic Alopecia

Interventions

DRUG

CB-03-01 solution

Investigational drug solution

DRUG

Minoxidil Solution 5%

FDA approved marketed product

DRUG

Placebo solution

Vehicle solution

Trial Locations (3)

Minnesota Clinical Study Center, Fridley

DermResearch, Inc., Austin

Therapeutics Clinical Research, San Diego